Overall , @ patients with clinical stage T@ or T@ prostate cancer underwent computed tomography ( CT ) and magnetic resonance imaging ( MRI ) scans for treatment planning , followed with fiducial marker placement , and were randomized to receive spacer injection or no injection ( control ) .